Effect of 6 wk of high-intensity one-legged cycling on functional sympatholysis and ATP signaling in patients with heart failure

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Effect of 6 wk of high-intensity one-legged cycling on functional sympatholysis and ATP signaling in patients with heart failure. / Munch, Gregers W; Iepsen, Ulrik W.; Ryrsø, Camilla K; Rosenmeier, Jaya B; Pedersen, Bente K; Mortensen, Stefan P.

In: American Journal of Physiology: Heart and Circulatory Physiology, Vol. 314, No. 3, 2018, p. H616-H626.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Munch, GW, Iepsen, UW, Ryrsø, CK, Rosenmeier, JB, Pedersen, BK & Mortensen, SP 2018, 'Effect of 6 wk of high-intensity one-legged cycling on functional sympatholysis and ATP signaling in patients with heart failure', American Journal of Physiology: Heart and Circulatory Physiology, vol. 314, no. 3, pp. H616-H626. https://doi.org/10.1152/ajpheart.00379.2017

APA

Munch, G. W., Iepsen, U. W., Ryrsø, C. K., Rosenmeier, J. B., Pedersen, B. K., & Mortensen, S. P. (2018). Effect of 6 wk of high-intensity one-legged cycling on functional sympatholysis and ATP signaling in patients with heart failure. American Journal of Physiology: Heart and Circulatory Physiology, 314(3), H616-H626. https://doi.org/10.1152/ajpheart.00379.2017

Vancouver

Munch GW, Iepsen UW, Ryrsø CK, Rosenmeier JB, Pedersen BK, Mortensen SP. Effect of 6 wk of high-intensity one-legged cycling on functional sympatholysis and ATP signaling in patients with heart failure. American Journal of Physiology: Heart and Circulatory Physiology. 2018;314(3):H616-H626. https://doi.org/10.1152/ajpheart.00379.2017

Author

Munch, Gregers W ; Iepsen, Ulrik W. ; Ryrsø, Camilla K ; Rosenmeier, Jaya B ; Pedersen, Bente K ; Mortensen, Stefan P. / Effect of 6 wk of high-intensity one-legged cycling on functional sympatholysis and ATP signaling in patients with heart failure. In: American Journal of Physiology: Heart and Circulatory Physiology. 2018 ; Vol. 314, No. 3. pp. H616-H626.

Bibtex

@article{4ddd7a5f0e8e4c53890af7300803a9ed,
title = "Effect of 6 wk of high-intensity one-legged cycling on functional sympatholysis and ATP signaling in patients with heart failure",
abstract = "Breathlessness during daily activities is the primary symptom in patients with heart failure (HF). Poor correlation between the hemodynamic parameters of left ventricular performance and perceived symptoms suggests that other factors, such as skeletal muscle function, play a role in determining exercise capacity. We investigated the effect of 6 wk of high-intensity, one-legged cycling (HIC; 8 × 4 at 90% one-legged cycling max) on 1) the ability to override sympathetic vasoconstriction (arterial infusion of tyramine) during one-legged knee-extensor exercise (KEE), 2) vascular function (arterial infusion of ACh, sodium nitroprusside, tyramine, and ATP), and 3) exercise capacity in HF patients with reduced ejection fraction ( n = 8) compared with healthy individuals ( n = 6). Arterial tyramine infusion lowered leg blood flow and leg vascular conductance at rest and during KEE before the training intervention in both groups ( P < 0.05) but not during KEE after the training intervention. There was no difference between groups. The peak vasodilatory response to ATP was blunted in HF patients ( P < 0.05), whereas there was no difference in ACh- and sodium nitroprusside-induced vasodilation between HF patients and healthy individuals. ACh-induced vasodilation increased in HF patients after the training intervention ( P < 0.05). HIC improved aerobic capacity in both groups ( P < 0.05), whereas only HF patients made improvements in the 6-min walking distance ( P < 0.05). These results suggest that exercise hyperemia and functional sympatholysis are not altered in HF patients and that functional sympatholysis is improved with HIC in both HF patients and healthy individuals. Moreover, these results suggest that the peak vasodilatory response to ATP is blunted in HF. NEW & NOTEWORTHY The ability to override sympathetic vasoconstrictor activity (by arterial tyramine infusion) during exercise is not different between heart failure patients and healthy individuals and is improved by high-intensity, one-legged cycling training. The peak vasodilatory response to ATP is reduced in heart failure patients.",
keywords = "Adenosine Triphosphate/administration & dosage, Aged, Bicycling, Denmark, Exercise Therapy/methods, Exercise Tolerance/drug effects, Female, Heart Failure/blood, Humans, Hyperemia/physiopathology, Lower Extremity, Male, Middle Aged, Muscle Contraction, Muscle, Skeletal/blood supply, Regional Blood Flow, Stroke Volume, Sympathetic Nervous System/drug effects, Sympathomimetics/administration & dosage, Time Factors, Treatment Outcome, Vasodilation/drug effects, Vasodilator Agents/administration & dosage, Ventricular Function, Left",
author = "Munch, {Gregers W} and Iepsen, {Ulrik W.} and Ryrs{\o}, {Camilla K} and Rosenmeier, {Jaya B} and Pedersen, {Bente K} and Mortensen, {Stefan P.}",
year = "2018",
doi = "10.1152/ajpheart.00379.2017",
language = "English",
volume = "314",
pages = "H616--H626",
journal = "American Journal of Physiology: Heart and Circulatory Physiology",
issn = "0363-6135",
publisher = "American Physiological Society",
number = "3",

}

RIS

TY - JOUR

T1 - Effect of 6 wk of high-intensity one-legged cycling on functional sympatholysis and ATP signaling in patients with heart failure

AU - Munch, Gregers W

AU - Iepsen, Ulrik W.

AU - Ryrsø, Camilla K

AU - Rosenmeier, Jaya B

AU - Pedersen, Bente K

AU - Mortensen, Stefan P.

PY - 2018

Y1 - 2018

N2 - Breathlessness during daily activities is the primary symptom in patients with heart failure (HF). Poor correlation between the hemodynamic parameters of left ventricular performance and perceived symptoms suggests that other factors, such as skeletal muscle function, play a role in determining exercise capacity. We investigated the effect of 6 wk of high-intensity, one-legged cycling (HIC; 8 × 4 at 90% one-legged cycling max) on 1) the ability to override sympathetic vasoconstriction (arterial infusion of tyramine) during one-legged knee-extensor exercise (KEE), 2) vascular function (arterial infusion of ACh, sodium nitroprusside, tyramine, and ATP), and 3) exercise capacity in HF patients with reduced ejection fraction ( n = 8) compared with healthy individuals ( n = 6). Arterial tyramine infusion lowered leg blood flow and leg vascular conductance at rest and during KEE before the training intervention in both groups ( P < 0.05) but not during KEE after the training intervention. There was no difference between groups. The peak vasodilatory response to ATP was blunted in HF patients ( P < 0.05), whereas there was no difference in ACh- and sodium nitroprusside-induced vasodilation between HF patients and healthy individuals. ACh-induced vasodilation increased in HF patients after the training intervention ( P < 0.05). HIC improved aerobic capacity in both groups ( P < 0.05), whereas only HF patients made improvements in the 6-min walking distance ( P < 0.05). These results suggest that exercise hyperemia and functional sympatholysis are not altered in HF patients and that functional sympatholysis is improved with HIC in both HF patients and healthy individuals. Moreover, these results suggest that the peak vasodilatory response to ATP is blunted in HF. NEW & NOTEWORTHY The ability to override sympathetic vasoconstrictor activity (by arterial tyramine infusion) during exercise is not different between heart failure patients and healthy individuals and is improved by high-intensity, one-legged cycling training. The peak vasodilatory response to ATP is reduced in heart failure patients.

AB - Breathlessness during daily activities is the primary symptom in patients with heart failure (HF). Poor correlation between the hemodynamic parameters of left ventricular performance and perceived symptoms suggests that other factors, such as skeletal muscle function, play a role in determining exercise capacity. We investigated the effect of 6 wk of high-intensity, one-legged cycling (HIC; 8 × 4 at 90% one-legged cycling max) on 1) the ability to override sympathetic vasoconstriction (arterial infusion of tyramine) during one-legged knee-extensor exercise (KEE), 2) vascular function (arterial infusion of ACh, sodium nitroprusside, tyramine, and ATP), and 3) exercise capacity in HF patients with reduced ejection fraction ( n = 8) compared with healthy individuals ( n = 6). Arterial tyramine infusion lowered leg blood flow and leg vascular conductance at rest and during KEE before the training intervention in both groups ( P < 0.05) but not during KEE after the training intervention. There was no difference between groups. The peak vasodilatory response to ATP was blunted in HF patients ( P < 0.05), whereas there was no difference in ACh- and sodium nitroprusside-induced vasodilation between HF patients and healthy individuals. ACh-induced vasodilation increased in HF patients after the training intervention ( P < 0.05). HIC improved aerobic capacity in both groups ( P < 0.05), whereas only HF patients made improvements in the 6-min walking distance ( P < 0.05). These results suggest that exercise hyperemia and functional sympatholysis are not altered in HF patients and that functional sympatholysis is improved with HIC in both HF patients and healthy individuals. Moreover, these results suggest that the peak vasodilatory response to ATP is blunted in HF. NEW & NOTEWORTHY The ability to override sympathetic vasoconstrictor activity (by arterial tyramine infusion) during exercise is not different between heart failure patients and healthy individuals and is improved by high-intensity, one-legged cycling training. The peak vasodilatory response to ATP is reduced in heart failure patients.

KW - Adenosine Triphosphate/administration & dosage

KW - Aged

KW - Bicycling

KW - Denmark

KW - Exercise Therapy/methods

KW - Exercise Tolerance/drug effects

KW - Female

KW - Heart Failure/blood

KW - Humans

KW - Hyperemia/physiopathology

KW - Lower Extremity

KW - Male

KW - Middle Aged

KW - Muscle Contraction

KW - Muscle, Skeletal/blood supply

KW - Regional Blood Flow

KW - Stroke Volume

KW - Sympathetic Nervous System/drug effects

KW - Sympathomimetics/administration & dosage

KW - Time Factors

KW - Treatment Outcome

KW - Vasodilation/drug effects

KW - Vasodilator Agents/administration & dosage

KW - Ventricular Function, Left

U2 - 10.1152/ajpheart.00379.2017

DO - 10.1152/ajpheart.00379.2017

M3 - Journal article

C2 - 29167117

VL - 314

SP - H616-H626

JO - American Journal of Physiology: Heart and Circulatory Physiology

JF - American Journal of Physiology: Heart and Circulatory Physiology

SN - 0363-6135

IS - 3

ER -

ID: 215461163